Venous Thromboembolism in Japanese Patients with Gynecologic Cancer

Objective Gynecologic cancer, including cervical, endometrial, and ovarian cancer, comprises the fifth leading type of cancer and is an important malignant disease in women. Previous studies in Western countries have reported respective prevalence rates for venous thromboembolism (VTE) of 3.3%–18.7%...

Full description

Bibliographic Details
Main Authors: Takahito Suzuki MD, Shota Tsurimoto MD, Takayasu Tada MD, Ryo Yamamura MD, Hiromasa Katoh MD, Yoshihiro Noji MD, Masato Yamaguchi MD, Susumu Fujino MD
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296221124121
_version_ 1811174245047205888
author Takahito Suzuki MD
Shota Tsurimoto MD
Takayasu Tada MD
Ryo Yamamura MD
Hiromasa Katoh MD
Yoshihiro Noji MD
Masato Yamaguchi MD
Susumu Fujino MD
author_facet Takahito Suzuki MD
Shota Tsurimoto MD
Takayasu Tada MD
Ryo Yamamura MD
Hiromasa Katoh MD
Yoshihiro Noji MD
Masato Yamaguchi MD
Susumu Fujino MD
author_sort Takahito Suzuki MD
collection DOAJ
description Objective Gynecologic cancer, including cervical, endometrial, and ovarian cancer, comprises the fifth leading type of cancer and is an important malignant disease in women. Previous studies in Western countries have reported respective prevalence rates for venous thromboembolism (VTE) of 3.3%–18.7%, 0.8%–8.1%, and 7.2%–20.9%. In this study, we aimed to identify the characteristics associated with VTE in Japanese patients. Methods We carried out a retrospective cohort study to compare the clinicopathological characteristics of patients with each gynecologic cancer with and without concomitant VTE. Patients: Patients with cervical, endometrial, or ovarian cancer treated at Fukui Prefectural Hospital, Japan, from April 2010 to March 2020. Results Among 699 patients with gynecologic cancer, 50 developed VTE within 5 years after their cancer diagnosis, including 16/357 patients with cervical cancer (5.6%), 12/185 with endometrial cancer (6.8%), and 22/157 with ovarian cancer (14.6%). The 1-year mortality rate after symptomatic VTE onset was 47.8%. The VTE group included significantly more older patients and more patients with advanced cancer or poor performance status compared with the non-VTE group. There was no significant difference in the rate of surgical treatment. Symptomatic, but not asymptomatic VTE, was associated with shorter survival. Conclusion Several baseline characteristics differed between patients with and without VTE. The incidences of VTE and some risk factors were similar in Japanese patients with gynecologic cancers compared with patients in other countries. Patients with VTE had some factors that worsened their prognosis, with patients with gynecologic cancer and symptomatic VTE having an especially poor prognosis.
first_indexed 2024-04-10T18:58:04Z
format Article
id doaj.art-936113fbb0364a23830daa05d88ef0e0
institution Directory Open Access Journal
issn 1938-2723
language English
last_indexed 2024-04-10T18:58:04Z
publishDate 2023-01-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj.art-936113fbb0364a23830daa05d88ef0e02023-01-31T16:34:45ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232023-01-012910.1177/10760296221124121Venous Thromboembolism in Japanese Patients with Gynecologic CancerTakahito Suzuki MDShota Tsurimoto MDTakayasu Tada MDRyo Yamamura MDHiromasa Katoh MDYoshihiro Noji MDMasato Yamaguchi MDSusumu Fujino MDObjective Gynecologic cancer, including cervical, endometrial, and ovarian cancer, comprises the fifth leading type of cancer and is an important malignant disease in women. Previous studies in Western countries have reported respective prevalence rates for venous thromboembolism (VTE) of 3.3%–18.7%, 0.8%–8.1%, and 7.2%–20.9%. In this study, we aimed to identify the characteristics associated with VTE in Japanese patients. Methods We carried out a retrospective cohort study to compare the clinicopathological characteristics of patients with each gynecologic cancer with and without concomitant VTE. Patients: Patients with cervical, endometrial, or ovarian cancer treated at Fukui Prefectural Hospital, Japan, from April 2010 to March 2020. Results Among 699 patients with gynecologic cancer, 50 developed VTE within 5 years after their cancer diagnosis, including 16/357 patients with cervical cancer (5.6%), 12/185 with endometrial cancer (6.8%), and 22/157 with ovarian cancer (14.6%). The 1-year mortality rate after symptomatic VTE onset was 47.8%. The VTE group included significantly more older patients and more patients with advanced cancer or poor performance status compared with the non-VTE group. There was no significant difference in the rate of surgical treatment. Symptomatic, but not asymptomatic VTE, was associated with shorter survival. Conclusion Several baseline characteristics differed between patients with and without VTE. The incidences of VTE and some risk factors were similar in Japanese patients with gynecologic cancers compared with patients in other countries. Patients with VTE had some factors that worsened their prognosis, with patients with gynecologic cancer and symptomatic VTE having an especially poor prognosis.https://doi.org/10.1177/10760296221124121
spellingShingle Takahito Suzuki MD
Shota Tsurimoto MD
Takayasu Tada MD
Ryo Yamamura MD
Hiromasa Katoh MD
Yoshihiro Noji MD
Masato Yamaguchi MD
Susumu Fujino MD
Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
Clinical and Applied Thrombosis/Hemostasis
title Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
title_full Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
title_fullStr Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
title_full_unstemmed Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
title_short Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
title_sort venous thromboembolism in japanese patients with gynecologic cancer
url https://doi.org/10.1177/10760296221124121
work_keys_str_mv AT takahitosuzukimd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT shotatsurimotomd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT takayasutadamd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT ryoyamamuramd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT hiromasakatohmd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT yoshihironojimd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT masatoyamaguchimd venousthromboembolisminjapanesepatientswithgynecologiccancer
AT susumufujinomd venousthromboembolisminjapanesepatientswithgynecologiccancer